These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38366255)

  • 21. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
    Smith J; Tho LM; Xu N; Gillespie DA
    Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldehyde dehydrogenase inhibitors promote DNA damage in ovarian cancer and synergize with ATM/ATR inhibitors.
    Grimley E; Cole AJ; Luong TT; McGonigal SC; Sinno S; Yang D; Bernstein KA; Buckanovich RJ
    Theranostics; 2021; 11(8):3540-3551. PubMed ID: 33664846
    [No Abstract]   [Full Text] [Related]  

  • 23. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.
    Helt CE; Cliby WA; Keng PC; Bambara RA; O'Reilly MA
    J Biol Chem; 2005 Jan; 280(2):1186-92. PubMed ID: 15533933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin-based Chemotherapy in Colorectal Cancer.
    Sundar R; Miranda S; Rodrigues DN; Chénard-Poirier M; Dolling D; Clarke M; Figueiredo I; Bertan C; Yuan W; Ferreira A; Chistova R; Boysen G; Perez DR; Tunariu N; Mateo J; Wotherspoon A; Chau I; Cunningham D; Valeri N; Carreira S; de Bono J
    Clin Colorectal Cancer; 2018 Dec; 17(4):280-284. PubMed ID: 30042009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATM regulates ATR chromatin loading in response to DNA double-strand breaks.
    Cuadrado M; Martinez-Pastor B; Murga M; Toledo LI; Gutierrez-Martinez P; Lopez E; Fernandez-Capetillo O
    J Exp Med; 2006 Feb; 203(2):297-303. PubMed ID: 16461339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.
    Tibbetts RS; Cortez D; Brumbaugh KM; Scully R; Livingston D; Elledge SJ; Abraham RT
    Genes Dev; 2000 Dec; 14(23):2989-3002. PubMed ID: 11114888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ATM and ATR Activation Through Crosstalk Between DNA Damage Response Pathways.
    Fedak EA; Adler FR; Abegglen LM; Schiffman JD
    Bull Math Biol; 2021 Mar; 83(4):38. PubMed ID: 33704589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific Human ATR and ATM Inhibitors Modulate Single Strand DNA Formation in
    da Silva RB; Bertoldo WDR; Naves LL; de Vito FB; Damasceno JD; Tosi LRO; Machado CR; Pedrosa AL
    Front Cell Infect Microbiol; 2021; 11():802613. PubMed ID: 35059327
    [No Abstract]   [Full Text] [Related]  

  • 29. Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide.
    Eich M; Roos WP; Nikolova T; Kaina B
    Mol Cancer Ther; 2013 Nov; 12(11):2529-40. PubMed ID: 23960094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative phosphoproteomics of the ataxia telangiectasia-mutated (ATM) and ataxia telangiectasia-mutated and rad3-related (ATR) dependent DNA damage response in Arabidopsis thaliana.
    Roitinger E; Hofer M; Köcher T; Pichler P; Novatchkova M; Yang J; Schlögelhofer P; Mechtler K
    Mol Cell Proteomics; 2015 Mar; 14(3):556-71. PubMed ID: 25561503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells.
    Moolmuang B; Ruchirawat M
    J Pharm Pharmacol; 2021 Mar; 73(1):40-51. PubMed ID: 33791808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression variations of DNA damage response genes ATM and ATR in blood cancer patients.
    Parvez A; Mahjabeen I; Mehmood A; Khan AU; Nisar A; Kayani MA
    Mol Genet Genomics; 2023 Sep; 298(5):1173-1183. PubMed ID: 37338595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imatinib inhibits inactivation of the ATM/ATR signaling pathway and recovery from adriamycin/doxorubicin-induced DNA damage checkpoint arrest.
    Morii M; Fukumoto Y; Kubota S; Yamaguchi N; Nakayama Y; Yamaguchi N
    Cell Biol Int; 2015 Aug; 39(8):923-32. PubMed ID: 25790472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATR and Chk1 suppress a caspase-3-dependent apoptotic response following DNA replication stress.
    Myers K; Gagou ME; Zuazua-Villar P; Rodriguez R; Meuth M
    PLoS Genet; 2009 Jan; 5(1):e1000324. PubMed ID: 19119425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Senescence Induction by Combined Ionizing Radiation and DNA Damage Response Inhibitors in Head and Neck Squamous Cell Carcinoma Cells.
    Dobler C; Jost T; Hecht M; Fietkau R; Distel L
    Cells; 2020 Sep; 9(9):. PubMed ID: 32883016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of switch from ATM to ATR signaling at the sites of DNA damage induced by low and high LET radiation.
    Saha J; Wang M; Cucinotta FA
    DNA Repair (Amst); 2013 Dec; 12(12):1143-51. PubMed ID: 24238855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers.
    Hocke S; Guo Y; Job A; Orth M; Ziesch A; Lauber K; De Toni EN; Gress TM; Herbst A; Göke B; Gallmeier E
    Oncotarget; 2016 Feb; 7(6):7080-95. PubMed ID: 26755646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment.
    Rozpędek W; Pytel D; Nowak-Zduńczyk A; Lewko D; Wojtczak R; Diehl JA; Majsterek I
    Curr Med Chem; 2019; 26(8):1425-1445. PubMed ID: 29345572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic Rationale to Target PTEN-Deficient Tumor Cells with Inhibitors of the DNA Damage Response Kinase ATM.
    McCabe N; Hanna C; Walker SM; Gonda D; Li J; Wikstrom K; Savage KI; Butterworth KT; Chen C; Harkin DP; Prise KM; Kennedy RD
    Cancer Res; 2015 Jun; 75(11):2159-65. PubMed ID: 25870146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting ATM and ATR for cancer therapeutics: Inhibitors in clinic.
    Priya B; Ravi S; Kirubakaran S
    Drug Discov Today; 2023 Aug; 28(8):103662. PubMed ID: 37302542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.